Alkem Laboratories Limited has intimated the National Stock Exchange of India Limited about a scheduled Analyst/Institutional Investor meeting. This is a compliance filing made with reference to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Type of Event: The event is a One-on-One meeting with an institutional investor.
- Date and Time: The meeting is scheduled for 7th October 2026. A specific time and time zone were not disclosed in the announcement.
- Participant: The meeting will be conducted with HDFC Mutual Fund.
- Format and Location: The meeting will be an In-person meeting to be held in Mumbai.
- Management Participants: The announcement does not specify which members of Alkem Laboratories' management will be participating in the meeting.
- Presentation/Availability of Materials: The document does not indicate that any presentation, earnings deck, transcript, or recording will be made available to the public.
- UPSI Statement: The company has not included any specific language indicating that no Unpublished Price Sensitive Information (UPSI) will be shared.
Additional Notes Section
- The document is a formal letter of intimation addressed to the National Stock Exchange of India Limited.
- The company explicitly states that the schedule of the meeting is subject to change due to exigencies on the part of either the Investor or the Company.
- The document was digitally signed by Divya Kumar and the correspondence is from Divya Mewani, Vice President – Legal & Deputy Company Secretary.
- No financial data, guidance, or strategic updates were disclosed in this announcement.